35.39
price up icon0.43%   0.15
 
loading

Vaxcyte Inc (PCVX) 最新ニュース

pulisher
May 01, 2025

Vaxcyte appoints new independent director - Investing.com Australia

May 01, 2025
pulisher
May 01, 2025

Vaxcyte appoints new independent director By Investing.com - Investing.com South Africa

May 01, 2025
pulisher
May 01, 2025

Vaxcyte (PCVX) Welcomes Former Sanofi CEO to Board of Directors | PCVX Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Vaxcyte Appoints Dr. Olivier Brandicourt to Board - TipRanks

May 01, 2025
pulisher
May 01, 2025

Vaxcyte adds former Sanofi CEO to its board - Investing.com

May 01, 2025
pulisher
May 01, 2025

Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors | PCVX Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors - GlobeNewswire

May 01, 2025
pulisher
Apr 29, 2025

Is Vaxcyte, Inc. (PCVX) the Best Oversold NASDAQ Stock to Buy Right Now? - Yahoo Finance

Apr 29, 2025
pulisher
Apr 26, 2025

US Stocks Dip As Investors Eye Trump's Tariff Announcements - Finimize

Apr 26, 2025
pulisher
Apr 24, 2025

James T. Wassil ’99G ’05G of Vaxcyte, Inc. Named Lehigh’s 2025 Graduate Commencement and Doctoral Hooding Ceremony Speaker - Lehigh University

Apr 24, 2025
pulisher
Apr 22, 2025

Vaxcyte (PCVX) Gains Attention with Overweight Rating Amid Marke - GuruFocus

Apr 22, 2025
pulisher
Apr 21, 2025

Vaxcyte (PCVX) Sees Surge in Investor Interest Amid Biotech Buzz - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Commit To Buy Vaxcyte At $20, Earn 14.7% Annualized Using Options - Nasdaq

Apr 21, 2025
pulisher
Apr 21, 2025

TD Cowen Keeps Their Buy Rating on Vaxcyte (PCVX) - The Globe and Mail

Apr 21, 2025
pulisher
Apr 19, 2025

Vaxcyte (PCVX) Stock Price, News & Analysis - MarketBeat

Apr 19, 2025
pulisher
Apr 18, 2025

When the Price of (PCVX) Talks, People Listen - news.stocktradersdaily.com

Apr 18, 2025
pulisher
Apr 17, 2025

2 ‘Strong Buy’ Growth Stocks That Could Gain More Than 340% - The Globe and Mail

Apr 17, 2025
pulisher
Apr 16, 2025

Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Apr 16, 2025
pulisher
Apr 12, 2025

Vaxcyte Stock Plummets 56% in a Month: Here's the Reason - MSN

Apr 12, 2025
pulisher
Apr 11, 2025

Vaxcyte Stock Plummets: What’s Next? - timothysykes.com

Apr 11, 2025
pulisher
Apr 11, 2025

Vaxcyte, Inc. (PCVX): Billionaire Stanley Druckenmiller’s Top Stock Pick with Huge Upside Potential - Insider Monkey

Apr 11, 2025
pulisher
Apr 09, 2025

Vaxcyte stock plunges to 52-week low at $29.53 amid market challenges - Investing.com India

Apr 09, 2025
pulisher
Apr 08, 2025

Vaxcyte stock plunges to 52-week low at $29.53 amid market challenges By Investing.com - Investing.com South Africa

Apr 08, 2025
pulisher
Apr 05, 2025

Vaxcyte (NASDAQ:PCVX) Price Target Lowered to $137.00 at Bank of America - MarketBeat

Apr 05, 2025
pulisher
Apr 02, 2025

InvestingPro Fair Value model correctly predicted Vaxcyte’s decline By Investing.com - Investing.com UK

Apr 02, 2025
pulisher
Apr 02, 2025

Vaxcyte (NASDAQ:PCVX) Given New $137.00 Price Target at Bank of America - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

(PCVX) Investment Analysis - news.stocktradersdaily.com

Apr 01, 2025
pulisher
Apr 01, 2025

Vaxcyte (PCVX) Stock Falls 45% Despite Positive Vaccine Trial Re - GuruFocus

Apr 01, 2025
pulisher
Apr 01, 2025

Vaxcyte ‘narrow’ misses in Phase 2 likely to be ok in Phase 3, says Evercore ISI - Yahoo Finance

Apr 01, 2025
pulisher
Apr 01, 2025

BofA lowers Vaxcyte price target, says selloff after infant data ‘overdone’ - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

Ulta Beauty To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

Vaxcyte stock sinks despite Phase II IPD vaccine trial success - Yahoo Finance

Apr 01, 2025
pulisher
Apr 01, 2025

Vaxcyte stock up on results from mid-stage trial of its pneumococcal vaccine - MSN

Apr 01, 2025
pulisher
Apr 01, 2025

Vaxcyte’s Promising Vaccine Potential and Market Expansion Drive Buy Rating - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

Goldman Sachs cuts Vaxcyte stock price target to $100 - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Goldman Sachs cuts Vaxcyte stock price target to $100 By Investing.com - Investing.com UK

Apr 01, 2025
pulisher
Apr 01, 2025

Vaxcyte’s Strong Phase 2 Data and Future Prospects Justify Buy Rating Despite Market Overreaction - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

Vaxcyte price target lowered to $90 from $140 at Needham - MSN

Apr 01, 2025
pulisher
Mar 31, 2025

Vaxcyte sights set on next results after ‘big moment’ with PCV - BioWorld MedTech

Mar 31, 2025
pulisher
Mar 31, 2025

Vaxcyte: Shares Tanking On Positive Data? Bad Time To Be A Vaccine Developer (NASDAQ:PCVX) - Seeking Alpha

Mar 31, 2025
pulisher
Mar 31, 2025

Sector Update: Health Care Stocks Higher Late Afternoon - MarketScreener

Mar 31, 2025
pulisher
Mar 31, 2025

Vaxcyte: Plunge On FDA Top Regulator Resigning Generates Buying Opportunity (NASDAQ:PCVX) - Seeking Alpha

Mar 31, 2025
pulisher
Mar 31, 2025

Jefferies maintains Buy on Vaxcyte stock, price target at $146 By Investing.com - Investing.com Canada

Mar 31, 2025
pulisher
Mar 31, 2025

Vaxcyte’s VAX-24: Promising Infant Vaccine Results Amidst Investor Concerns - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Optimistic Outlook for Vaxcyte: Potential for Improved Vaccine Efficacy in Future Trials - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Vaxcyte falls as pneumococcal vaccine data fails to meet lofty investor expectations - TradingView

Mar 31, 2025
$72.30
price down icon 0.47%
$21.48
price up icon 2.63%
$32.89
price up icon 1.26%
$27.90
price up icon 13.09%
$104.94
price up icon 2.45%
biotechnology ONC
$255.77
price up icon 0.05%
大文字化:     |  ボリューム (24 時間):